Literature DB >> 2951197

Congenital malformations in babies of diabetic mothers.

C Lowy, R W Beard, J Goldschmidt.   

Abstract

In 1979-80 a national survey of the incidence of congenital malformations in babies born to diabetic mothers in the United Kingdom was carried out by questionnaire. Of the 1034 mothers reported, 773 were known to have diabetes before the index pregnancy. The incidence of congenital malformations ws 7.1% which is significantly higher than the 2.1% in the offspring reported to the Office of Population, Censuses and Surveys (OPCS) for England and Wales in 1979-80. The increase was most pronounced for malformations of the heart, spine, lungs, and brain. In 40% of the diabetic mothers blood glucose was not recorded during the first trimester of pregnancy, and in this group the malformation rate was twice that in babies born of mothers who had had at least one reported blood glucose estimation during this time. We conclude that there is an urgent need to improve health education and supervision before and during pregnancy in all diabetic women if the prevalence of malformations amongst their offspring is to be reduced.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2951197     DOI: 10.1111/j.1464-5491.1986.tb00791.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  3 in total

1.  Congenital cardiac anomalies relative to selected maternal exposures and conditions during early pregnancy.

Authors:  G M Shaw; L H Malcoe; S H Swan; S K Cummins; J Schulman
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

Review 2.  Getting to the heart of the matter: epidemiology of cyanotic heart defects.

Authors:  Jennifer L Kornosky; Hamisu M Salihu
Journal:  Pediatr Cardiol       Date:  2008-01-10       Impact factor: 1.655

3.  Prevention: the cost-effectiveness of the California Diabetes and Pregnancy Program.

Authors:  R M Scheffler; L B Feuchtbaum; C S Phibbs
Journal:  Am J Public Health       Date:  1992-02       Impact factor: 9.308

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.